Epstein Secrets

CVI Investments, Inc.

Shared Docs

Same-Page

7 / 7

Mentions

Document Mentions (7 shared documents)

EFTA00070362_email_005

2 mentions1 same-page

Page ?Same page

sting public it is mandated to protect. "SEC charges Company and Two Executives for Misleading COVID-19 Disclosures" Let that sink in for a minute Parallax Health Sciences, Inc., Paul Arena and Nathaniel Bradley (sec.gov) EFTA00070413 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK 5 . FACTUAL BACKGROUND 13. At

g Men in Cemtrex also: CVI/Susquehana EDGAR Filing Documents for 0001104659-21-023193 (sec.gov) EDGAR Filing Documents for 0001104659-21-023193 CVI Investments, Inc. (Filed by) CIK: 0001649553 (see all company filings) IRS No.: 981253664 I State of Incorp.:E9 I Fiscal Year End: 1231 Type: SC 13G/ASC 13G/A viww.

EFTA00070202_email_002

2 mentions1 same-page

Page ?Same page

sting public it is mandated to protect. "SEC charges Company and Two Executives for Misleading COVID-19 Disclosures" Let that sink in for a minute Parallax Health Sciences, Inc., Paul Arena and Nathaniel Bradley (sec.gov) UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK S . FACTUAL BACKGROUND 13. At all times rele

EFTA00070043_email_003

2 mentions1 same-page

Page ?Same page

sting public it is mandated to protect. "SEC charges Company and Two Executives for Misleading COVID-19 Disclosures" Let that sink in for a minute Parallax Health Sciences, Inc., Paul Arena and Nathaniel Bradley (sec.gov) EFTA00070086 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK 5 . FACTUAL BACKGROUND 13. At

Sponsored

EFTA00080676_email_003

2 mentions1 same-page

Page ?Same page

sting public it is mandated to protect. "SEC charges Company and Two Executives for Misleading COVID-19 Disclosures" Let that sink in for a minute Parallax Health Sciences, Inc., Paul Arena and Nathaniel Bradley (sec.gov) UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK S . FACTUAL BACKGROUND 13. At all times rele

x EFTA00080695 also: CVI/Susquehana EDGAR Filing Documents for 0001104659-21-023193 (sec.gov) EDGAR Filing Documents for 0001104659-21-023193 CVI Investments, Inc. (Filed by) CIK: 0001649553 (see all company filings) IRS No.: 981253664 I State of Incorp.:E9 I Fiscal Year End: 1231 Type: SC 13G/ASC 13G/A www se

EFTA00069571_email_003

2 mentions1 same-page

Page ?Same page

sting public it is mandated to protect. "SEC charges Company and Two Executives for Misleading COVID-19 Disclosures" Let that sink in for a minute Parallax Health Sciences, Inc., Paul Arena and Nathaniel Bradley (sec.gov) EFTA00069601 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK 5 . FACTUAL BACKGROUND 13. At

EFTA00071140_email_003

2 mentions1 same-page

Page ?Same page

sting public it is mandated to protect. "SEC charges Company and Two Executives for Misleading COVID-19 Disclosures" Let that sink in for a minute Parallax Health Sciences, Inc., Paul Arena and Nathaniel Bradley (sec.gov) EFTA00071169 UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK 5 . FACTUAL BACKGROUND 13. At

Sponsored

EFTA00065103

2 mentions1 same-page

Page ?Same page

sting public it is mandated to protect. "SEC charges Company and Two Executives for Misleading COVID-19 Disclosures" Let that sink in for a minute Parallax Health Sciences, Inc., Paul Arena and Nathaniel Bradley (sec.gov) UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK S . FACTUAL BACKGROUND 13. At all times rele

Sponsored

Mutual Connections (232)

Entities connected to both Parallax Health Sciences, Inc. and CVI Investments, Inc.

Dick Best

Chris Dilorio

Donald Trump

Supreme Court

Pasquinelli

13 w/ Parallax·16 w/ CVI

Norberg

13 w/ Parallax·16 w/ CVI

Berger Montague

13 w/ Parallax·15 w/ CVI

Gensler

13 w/ Parallax·12 w/ CVI

SEC NY

8 w/ Parallax·17 w/ CVI

Julian Tiederman

Vicon Industries, Inc.

NYC Ferry

LOCATION

Michael Milken

13 w/ Parallax·11 w/ CVI

Ayrton Capital LLC

Key Tronics

Deregister Common Stock

Govil/Cemtrex

Goldman Sachs

13 w/ Parallax·11 w/ CVI

Greenpoint Ave Brooklyn

Ms Mehraban et al